SC 13G/A

AMENDMENT NO. 2 TO SCHEDULE 13G

Company: Protalix BioTherapeutics, Inc.
Filed: February 12, 2018
Accession Number: 0001213900-18-001569

View Document ↗ View on SEC.gov ↗